Phase I study of humanized IgG1 anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 plus gemcitabine (Gem) in advanced pancreatic cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3061 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3061-3061

Author(s):

U. Graeven ◽

I. Vogel ◽

B. Killing ◽

S. Hinz ◽

W. Von Bernstorff ◽

...

Keyword(s):

Pancreatic Cancer ◽

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Advanced Pancreatic Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

Phase I study of humanized IgG1 anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 plus gemcitabine (Gem) in advanced pancreatic cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3061 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3061-3061 ◽

Author(s):

U. Graeven ◽

I. Vogel ◽

B. Killing ◽

S. Hinz ◽

W. Von Bernstorff ◽

...

Keyword(s):

Pancreatic Cancer ◽

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Advanced Pancreatic Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

A Phase I Study of an Anti-epidermal Growth Factor Receptor Monoclonal Antibody for the Treatment of Malignant Gliomas

Neurosurgery ◽

10.1097/00006123-199609000-00009 ◽

1996 ◽

Vol 39 (3) ◽

pp. 478-483 ◽

Author(s):

Thierry Faillot ◽

Henri Magdelénat ◽

Essam Mady ◽

Paul Stasiecki ◽

Denis Fohanno ◽

...

Keyword(s):

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Malignant Gliomas ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Monoclonal Antibody

Download Full-text

A randomized phase I study of the humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 in subjects with advanced gastrointestinal cancers

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3018 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3018-3018 ◽

Author(s):

T. Trarbach ◽

T. Beyer ◽

N. Schleucher ◽

J. Stattaus ◽

S. P. Mueller ◽

...

Keyword(s):

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Growth Factor Receptor ◽

Gastrointestinal Cancers ◽

Epidermal Growth

Download Full-text

A Phase I Study of an Anti-epidermal Growth Factor Receptor Monoclonal Antibody for the Treatment of Malignant Gliomas

Neurosurgery ◽

10.1227/00006123-199609000-00009 ◽

1996 ◽

Vol 39 (3) ◽

pp. 478-483

Author(s):

Thierry Faillot ◽

Henri Magdelénat ◽

Essam Mady ◽

Paul Stasiecki ◽

Denis Fohanno ◽

...

Keyword(s):

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Malignant Gliomas ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Monoclonal Antibody

Download Full-text

1247 Phase I study of nimotuzumab, a humanized anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in Japanese patients with solid tumors

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70459-8 ◽

2009 ◽

Vol 7 (2) ◽

pp. 134

Author(s):

N. Boku ◽

K. Yamazaki ◽

A. Fukutomi ◽

T. Takahashi ◽

N. Yamamoto ◽

...

Keyword(s):

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Growth Factor Receptor ◽

Japanese Patients ◽

Igg1 Monoclonal Antibody ◽

Epidermal Growth

Download Full-text

A first-in-human phase I study of GC1118, a novel monoclonal antibody inhibiting epidermal growth factor receptor (EGFR), in patients with colorectal cancer and gastric/GEJ cancer

Annals of Oncology ◽

10.1093/annonc/mdy281.112 ◽

2018 ◽

Vol 29 ◽

pp. viii189

Author(s):

D.-Y. Oh ◽

K.-W. Lee ◽

S.-W. Han ◽

J.W. Kim ◽

J.-W. Shin ◽

...

Keyword(s):

Colorectal Cancer ◽

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Growth Factor Receptor ◽

Epidermal Growth

Download Full-text

A randomized phase I study of the humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody EMD 72000 in subjects with advanced gastrointestinal cancers

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3018 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3018-3018

Author(s):

T. Trarbach ◽

T. Beyer ◽

N. Schleucher ◽

J. Stattaus ◽

S. P. Mueller ◽

...

Keyword(s):

Monoclonal Antibody ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Phase I Study ◽

Growth Factor Receptor ◽

Gastrointestinal Cancers ◽

Epidermal Growth

Download Full-text

Faculty Opinions recommendation of Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14346.471799 ◽

2006 ◽

Author(s):

Jeffrey Evans

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Growth Factor Receptor ◽

Advanced Solid Tumors ◽

Irreversible Inhibitor ◽

Epidermal Growth

Download Full-text

Epidermal growth factor receptor-targeted treatment strategies in advanced pancreatic cancer: Is K-RAS mutational testing ready for prime time?

memo - Magazine of European Medical Oncology ◽

10.1007/s12254-011-0302-3 ◽

2011 ◽

Vol 4 (4) ◽

pp. 257-259

Author(s):

T. Bauernhofer

Keyword(s):

Pancreatic Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Advanced Pancreatic Cancer ◽

Treatment Strategies ◽

Growth Factor Receptor ◽

Targeted Treatment ◽

Epidermal Growth

Download Full-text

A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1383-0 ◽

2010 ◽

Vol 67 (4) ◽

pp. 891-897 ◽

Author(s):

J. P. Arnoletti ◽

A. Frolov ◽

M. Eloubeidi ◽

K. Keene ◽

J. Posey ◽

...

Keyword(s):

Pancreatic Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Phase I Study ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Download Full-text